Para Snow Sports classification: Part 2 The process of classification
Jul 17, 2025 - Learn about all aspects of the classification process across…
ISC2 Research Reveals Cybersecurity Teams Are Taking a Cautious Approach to AI Adoption
New study reveals 30% of cybersecurity professionals are already using AI tools,…
CGTN: Bridging dialogue: China promotes integration, mutual learning among civilizations
With the Global Civilizations Dialogue Ministerial Meeting taking place in Beijing on…
CGTN: Why does China honor the spirit of resisting aggression?
BEIJING, July 9, 2025 /PRNewswire/ -- CGTN has published an article on…
Clarivate Releases 2025 G20 Research and Innovation Scorecard Highlighting Global Collaboration and Impact
New Data Reveals Shifting Global Partnerships, Rising Open Access, and Focus on…
Euro NCAP to Launch New Round of 2025 Safety Results
WhatLatest Euro NCAP safety results published online and via social media.WhenWednesday 9…
Para Snow Sports classification: Part 1 Research and collaboration to ensure fair competition
Jul 04, 2025 - Learn about all aspects of the classification process across…
NEXEN TIRE Releases 2024/25 Sustainability Report, Strengthens ESG Commitments Across Global Operations
First-time inclusion of consolidated global performance data from 10 international sitesExpanded focus…
Novo Nordisk A/S: CagriSema 2.4 mg / 2.4 mg demonstrated 22.7% mean weight reduction in adults with overweight or obesity in REDEFINE 1, published in New England Journal of Medicine
Data presented simultaneously at the American Diabetes Association’s® 85th Scientific Sessions, showed…
Novo Nordisks subcutaneous and oral amycretin data published in The Lancet and presented at ADA 2025
Subcutaneous amycretin phase 1b/2a data on the safety, tolerability and weight loss…